Overview

A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders

Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is assessing the efficacy of swallowed Flovent® vs. placebo for the treatment of eosinophilic esophagitis (EE).
Phase:
Phase 3
Details
Lead Sponsor:
Marc Rothenberg
Treatments:
Fluticasone
Xhance